Prices are updated after-hours

LAB

Standard BioTools Inc

LAB | $2.42 -5.47% -5.79% 2.3M

(0.0% 1d) (-5.2% 1m) (54.2% 1y) (0.0% 2d) (0.8% 3d) (1.6% 7d) (-0.88% volume)
Earnings Calendar:
Market Cap: $ 702,085,391
https://www.fluidigm.com
Sec Filling | Patents | 627 employees

(US) Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.

immunotherapy cancer animals

add to watch list Paper trade email alert is off

Press-releases

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| -3.4% | O: 4.15% H: 6.7% C: 4.35%
set imaging

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| -3.76% | O: 5.26% H: 4.64% C: -5.36%
somascan multi-year research platform

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| -2.29% | O: -0.38% H: 2.3% C: -0.77%
series

Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 4.49% | O: -1.63% H: 4.56% C: -1.24%
partnership gen diagnostics

Standard BioTools to Participate in Upcoming Investor Conferences
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 8.94% | O: -0.43% H: 7.48% C: 4.7%

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Published: 2024-02-14 (Crawled : 14:00) - biospace.com/
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 9.87% | O: 0.0% H: 4.29% C: 1.29%
conference year financial results

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine
Published: 2024-02-07 (Crawled : 13:30) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 7.11% | O: 0.42% H: 1.67% C: -1.25%
collaboration imaging agreement

Global Microfluidic Devices Market to Surge to US$ 45.18 Billion by 2030 with Technological Advancements Driving Growth
Published: 2024-01-25 (Crawled : 02:00) - prnewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 9.4% | O: -0.43% H: 1.72% C: 1.29%
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 3.01% | O: -1.03% H: 0.84% C: -0.92%
PHG | News | $20.97 -0.19% 0.0% 650K

Health Technology

| -8.01% | O: 0.0% H: 0.57% C: 0.48%
DHR | $250.41 -1.07% -0.72% 3.3M

Health Technology

| 10.72% | O: 1.19% H: 0.34% C: -1.7%
BDX | $233.83 -0.23% 3.49% 780K

Health Technology

| -0.09% | O: 0.48% H: 0.45% C: 0.37%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -2.98% | O: 0.47% H: 1.04% C: 0.93%
OPK | $1.225 -2.0% -2.04% 6.1M

Health Technology

| 25.13% | O: 1.1% H: 0.0% C: -2.26%
ILMN | $122.74 -1.38% -1.4% 1.2M

Health Technology

| -11.74% | O: 1.9% H: 0.79% C: -0.65%
global growth market

Global Polymerase Chain Reaction (PCR) Technology and Market Analysis Report 2023-2028: Innovations Drive Market Expansion, Digital PCR (dPCR) Emerges as the Fastest-Growing PCR Technology
Published: 2024-01-09 (Crawled : 19:00) - prnewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 24.27% | O: -0.97% H: 0.0% C: -5.88%
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 4.35% | O: -0.2% H: 1.58% C: 0.58%
BDX | $233.83 -0.23% 3.49% 780K

Health Technology

| -1.46% | O: 0.06% H: 0.73% C: 0.18%
A | $137.49 -1.23% -0.36% 1.6M

Health Technology

| 6.52% | O: -0.08% H: 0.44% C: 0.39%
report global technology market

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing

| 36.9% | O: 0.0% H: 16.84% C: 13.37%
year revenue

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000950170-24-043103	4	2024-04-09	2024-04-08	Sell	F	102564	531592
0000950170-24-042373	4	2024-04-05	2024-04-04	Sell	M	196512	393025
0000950170-24-042373	4	2024-04-05	2024-04-05	Buy	A	212126	634156
0000950170-24-042373	4	2024-04-05	2024-04-04	Buy	M	196512	422030
0000950170-24-042373	4	2024-04-05	2024-01-05	Buy	A	9006	225518
0000950170-24-042372	4	2024-04-05	2024-04-04	Sell	M	70183	140366
0000950170-24-042372	4	2024-04-05	2024-04-05	Buy	A	70702	211068
0000950170-24-042372	4	2024-04-05	2024-04-04	Buy	M	70183	140366